SOURCE: Lenstec, Inc.

July 11, 2006 09:20 ET

Lenstec, Inc. Launches European Expansion With New Barcelona Sales Office

Ophthalmic Industry Sales and Product Management Expert Josep M. Aler Appointed to Direct New Spain-Based Operations

ST. PETERSBURG, FL and BARCELONA -- (MARKET WIRE) -- July 11, 2006 -- Lenstec, Inc. -- a provider of technologically advanced lens implants and devices used in cataract and refractive surgery -- today announced the opening of its new Barcelona sales office, which will help the company meet growing European demand for its products.

Lenstec Spain expands the company's existing European operations, which include a UK sales and marketing office in Yorkshire, England. The new Barcelona office will serve France, Portugal and the fast-growing Spanish market, which accounts for one of Europe's highest volumes of refractive surgery procedures.

"Lenstec Spain will advance our global strategy by enabling us to sell products directly to surgeons in these high-growth regions," said Lenstec CEO and Chairman John Clough. "Our goal is to make new technologies such as the Tetraflex™ accommodating IOL and Softec aberration-controlled cataract lenses readily available across key markets in Europe, Southeast Asia and the Americas."

The company also announced that Josep Manuel Aler has been appointed to lead the new Barcelona office. He joins Lenstec with more than 15 years of ophthalmic and high-tech industry experience.

"We are delighted to have Josep on board to spearhead our expanded presence in Europe," said Clough. "He brings the ideal blend of skills and experience necessary to position Lenstec for growth as we become a truly global company."

Prior to joining Lenstec, Aler held senior level sales, marketing and product management positions with leading international ophthalmic firms including Eyeonics and Wavelight, as well as regional diagnostic and clinical device supplier Bloss Group.

Aler added, "Lenstec already has high brand awareness among European surgeons. I look forward to helping the company expand in nations where demand for refractive surgery is growing rapidly."

Lenstec's Tetraflex™ accommodating IOL has been available commercially in Europe since 2003. The Softec HD lens is a new aspheric aberration-controlled IOL recently introduced to the European market. Both join Lenstec's expanding line of technologically advanced intraocular lens implants.

The company's new Barcelona office joins its existing sales office in the UK, as well as corporate/R&D headquarters in Florida and manufacturing facilities in Barbados. For more information about Lenstec Spain, please contact Josep Manuel Aler at jmaler@lenstec.com or via phone at +34 607 182 745.

About Lenstec

Lenstec, Inc. is a leading provider of medical devices used by ophthalmic surgeons to treat vision disorders. The company designs, manufacturers and distributes a wide range of intraocular lens (IOL) implants and lens injection systems, including the industry-leading SoftecHD IOL, Tetraflex presbyopic IOL and Precision Series™ IOLs. Proprietary lens manufacturing technology enables the company to produce premium lenses with reduced variability and improved surgical predictability. Founded in 1992, Lenstec is dedicated to advancing possibilities for ophthalmic surgeons and their patients worldwide. More information about Lenstec is available at www.lenstec.com.

Contact Information